Your Web News in One Place

Help Webnuz

Referal links:

Sign up for GreenGeeks web hosting
November 14, 2018 01:06 am GMT

Roivant Sciences, a four-year-old biotech holding company, just raised $200 million in fresh funding at a whopping $7 billion valuation

Roivant Sciences has had a bumpy couple of years, but that isn’t stopping investors from pouring more money into the four-year-old company, which aims to one day be a giant holding company for dozens of independent biopharmaceutical spinoffs — and is fulfilling that vision by creating one independent company at a time. Roivant’s newest financing […]

Original Link: http://feedproxy.google.com/~r/Techcrunch/~3/wj6wvXjAJWM/

Share this article:    Share on Facebook
View Full Article

Techcrunch

TechCrunch is a leading technology blog, dedicated to obsessively profiling startups, reviewing new Internet products, and breaking tech news.

More About this Source Visit Techcrunch